Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

Soluble CD83 can treat alopecia areata by activating immune cells.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

The document concludes that early and accurate diagnosis of hair loss on the top of the scalp in Black men is important to distinguish CCCA from other types of hair loss.

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Platelet-rich plasma treatment is effective for hair loss in patients regardless of their thyroid antibody levels.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

Celiac disease requires more than just a gluten-free diet for effective management.

An 18-year-old girl improved with treatment after being diagnosed with both Systemic Lupus Erythematosus and Celiac Disease.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

A woman experienced severe symptoms, including hair loss, after a COVID-19 vaccine, suggesting a possible autoimmune reaction.

Belatacept may be a promising treatment for alopecia areata.

Lower GATA3 levels in mice help hair regrow by changing certain immune cells.

Black women with CCCA are more likely to have uterine fibroids.

APCs may improve hair density in cicatricial alopecia but effects may not last long.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

CCCA affects Black men too, with a genetic link found in the PADI3 gene.

CCCA can affect both genders and all ages, and it has a genetic component.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

A simple test can help diagnose a rare bruising disorder after ruling out other causes.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Thymus-derived Tregs, not peripherally-derived Tregs, primarily regulate type 1 diabetes in the NOD mouse model.